Please Wait
Applying Filters...
menu
    • menu
    Sanofi-PSE
    News
    Sanofi's $1.1B eczema drug hits goal, spurring talk of phase 3

    28 Jun 2023

    // Nick Paul Taylor FIERCE BIOTECH

    Incyte pens $885M AI pact to use Genesis' GEMS to develop drugs

    21 Feb 2025

    // FIERCE BIOTECH

    AstraZeneca boosts China presence with FibroGen's anemia drug in $160M deal

    21 Feb 2025

    // REUTERS

    Data Compilation
    #PharmaFlow

    Sanofi

    Contact Supplier

    Website

    BioAsia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Menu

    Kymab

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi's $1.1B eczema drug hits goal, spurring talk of phase 3
    Sanofi's $1.1B eczema drug hits goal, spurring talk of phase 3

    28 Jun 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sanofis-11b-eczema-drug-hits-midphase-goal-spurring-talk-phase-3-and-new-indications

    Nick Paul Taylor FIERCE BIOTECH
    28 Jun 2023
    Share Share